TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,265.00
-130.00 (-5.43%)
Oct 8, 2026, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17,46326,1253,3068,5199,73423,195
Short-Term Investments
13,116-7312,000--
Trading Asset Securities
6,0006,0006,000---
Cash & Short-Term Investments
36,57832,12510,03710,5199,73423,195
Cash Growth
283.86%220.07%-4.58%8.07%-58.04%-6.21%
Accounts Receivable
11,7018,1008,7388,9916,1399,479
Other Receivables
1,311870.46242.79177.97267.88224.23
Receivables
13,15917,0499,06016,2226,4399,703
Inventory
15,7755,1234,9565,0034,6224,303
Prepaid Expenses
628.24265.68223.4283.273.7498.87
Other Current Assets
3,2733,1721,7351,1612,25855.98
Total Current Assets
69,41457,73526,01132,98923,12737,357
Property, Plant & Equipment
24,6759,87711,1808,4688,0389,320
Long-Term Investments
35,56170,21394,88674,80063,37590,287
Other Intangible Assets
21,02016,23418,73821,33823,88130,201
Long-Term Accounts Receivable
154.75-----0
Other Long-Term Assets
36,1222,5512,7032,774799.52864.83
Total Assets
187,218156,668153,588140,415119,255168,030

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3,9013,1422,8182,5812,6682,630
Accrued Expenses
2,7571,173899.94697.9720.39901.94
Short-Term Debt
56,41232,30854,66326,44328,85353,991
Current Portion of Long-Term Debt
1,120-00000
Current Portion of Leases
1,796527.59437.95577.16694.1644.11
Other Current Liabilities
14,0169,10910,9014,6251,3941,946
Total Current Liabilities
80,00146,25969,72034,92434,32960,113
Long-Term Debt
700-----
Long-Term Leases
3,1191,433589.71403.02727.851,301
Long-Term Deferred Tax Liabilities
638.86-----
Other Long-Term Liabilities
1,055157.61143.39143.4162.777.91
Total Liabilities
87,73347,85070,45335,47035,12061,422

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,15268,52412,02511,59910,8609,991
Additional Paid-In Capital
228,319229,052245,985243,907238,108216,003
Retained Earnings
-148,477-191,918-180,462-154,142-168,048-126,310
Treasury Stock
-13,921-56.04-56.04---
Comprehensive Income & Other
271.222,8995,3373,0943,2036,896
Total Common Equity
73,344108,50182,830104,45984,123106,580
Minority Interest
26,140317.35305.35485.4612.2627.59
Shareholders' Equity
99,484108,81883,135104,94584,135106,608
Total Liabilities & Equity
187,218156,668153,588140,415119,255168,030

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
63,14734,26855,69127,42330,27555,936
Net Cash (Debt)
-26,569-2,143-45,654-16,904-20,542-32,741
Net Cash Growth
------
Net Cash Per Share
-4346.05-446.86-12869.32-3767.91-4985.94-12423.17
Filing Date Shares Outstanding
5.626.853.63.483.263
Total Common Shares Outstanding
5.626.853.613.483.263
Working Capital
-10,58711,475-43,709-1,935-11,202-22,756
Book Value Per Share
13047.6015836.2922960.3330018.2925819.4435559.09
Tangible Book Value
52,32492,26764,09283,12160,24276,379
Tangible Book Value Per Share
9308.2313466.8117766.1823886.3918489.6825482.97
Land
8,667827.37827.37827.37827.37827.37
Buildings
9,9335,4075,5765,2814,9744,867
Machinery
18,20411,85810,7208,7028,0167,927
Construction In Progress
1,38177.61,027-325316